|
ATE258067T1
(de)
*
|
1995-05-26 |
2004-02-15 |
Pfizer |
Kombinationspräparat zur behandlung der parkinsonschen krankheit, das selektive nmda- antagonisten enthält
|
|
DE69834500T2
(de)
*
|
1997-09-05 |
2007-05-03 |
Kyowa Hakko Kogyo Co., Ltd. |
Xanthinderivative zur behandlung von hirnischämie
|
|
WO2000067803A1
(en)
|
1999-05-10 |
2000-11-16 |
Princeton University |
Compositions and methods for improving learning and memory
|
|
US6432976B1
(en)
|
1999-10-29 |
2002-08-13 |
Merck & Co., Inc. |
8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
|
|
US6489477B1
(en)
|
1999-10-29 |
2002-12-03 |
Merck & Co., Inc. |
2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
|
|
US6369076B1
(en)
|
1999-10-29 |
2002-04-09 |
Merck & Co. Inc. |
5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
|
|
AU1153601A
(en)
|
1999-10-29 |
2001-05-08 |
Merck Sharp & Dohme Limited |
Method to treat pain utilizing benzimidazole NMDA NR2B antagonists
|
|
US6476041B1
(en)
|
1999-10-29 |
2002-11-05 |
Merck & Co., Inc. |
1,4 substituted piperidinyl NMDA/NR2B antagonists
|
|
US6316474B1
(en)
|
1999-10-29 |
2001-11-13 |
Merck & Co., Inc. |
2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
|
|
US6291499B1
(en)
|
1999-10-29 |
2001-09-18 |
Merck & Co., Inc. |
2-cyclohexyl benzimidazole NMDA/NR2B antagonists
|
|
GB0015488D0
(en)
|
2000-06-23 |
2000-08-16 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1296958A4
(en)
|
2000-06-26 |
2004-01-28 |
Merck & Co Inc |
ANTIAGONISTS OF NMDA NR2B RECEPTORS OF IMINOPYRIMIDINE
|
|
WO2002009736A1
(en)
|
2000-07-27 |
2002-02-07 |
Washington University |
Methods and agents for treating persistent pain
|
|
AU2001280996A1
(en)
|
2000-08-04 |
2002-02-18 |
Cis Biotech, Inc. |
Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
|
|
HU227197B1
(en)
|
2000-10-24 |
2010-10-28 |
Richter Gedeon Nyrt |
Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
|
|
PL364625A1
(en)
|
2001-02-23 |
2004-12-13 |
Merck & Co, Inc. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
|
CA2443108A1
(en)
|
2001-04-03 |
2002-10-17 |
Merck & Co. Inc. |
N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
|
|
JP2004537526A
(ja)
|
2001-06-12 |
2004-12-16 |
メルク エンド カムパニー インコーポレーテッド |
片頭痛の治療又は予防用ｎｒ２ｂ受容体拮抗薬
|
|
CA2453383C
(en)
|
2001-07-24 |
2010-04-06 |
Richter Gedeon Vegyeszeti Gyar Rt |
Piperidine derivatives as nmda receptor antagonists
|
|
AU2003230758A1
(en)
|
2002-04-02 |
2003-10-20 |
Merck And Co., Inc. |
5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
|
|
US6713490B2
(en)
|
2002-04-26 |
2004-03-30 |
Pfizer, Inc. |
3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
|
|
JP2006509763A
(ja)
|
2002-11-22 |
2006-03-23 |
メルク エンド カムパニー インコーポレーテッド |
Ｎｒ２ｂ受容体アンタゴニストとしての２−［（４−ベンジル）−１−ピペリジニル）メチル］ベンゾイミダゾール−５−オール誘導体
|
|
AU2003303042A1
(en)
|
2002-12-17 |
2004-07-09 |
Pfizer Inc. |
2-pyridyl and 2-pyrimidyl cycloalkylene amide compounds as nr2b receptor antagonists
|
|
US20060106040A1
(en)
|
2002-12-19 |
2006-05-18 |
Michael Grzelak |
Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
|
|
US20060128694A1
(en)
|
2002-12-19 |
2006-06-15 |
Michael Grzelak |
Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
|
|
BRPI0409241A
(pt)
|
2003-04-10 |
2006-03-28 |
Pfizer |
compostos bicìclicos como antagonistas do receptor de nr2b, composições farmacêuticas compreendendo os mesmos e seu uso
|
|
SI1648882T1
(sl)
|
2003-06-04 |
2009-02-28 |
Merck & Co Inc |
3-fluoro-piperidini kot nmda/nr2b antagonisti
|
|
DE602004004278T2
(de)
|
2003-08-15 |
2007-10-31 |
Merck & Co, Inc. |
4-cycloalkylaminopyrazolopyrimidin als nmda/nr2b-antagonisten
|
|
WO2005019222A1
(en)
|
2003-08-15 |
2005-03-03 |
Merck & Co., Inc. |
4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists
|
|
JP4737418B2
(ja)
|
2003-09-25 |
2011-08-03 |
塩野義製薬株式会社 |
Ｎｍｄａ受容体拮抗作用を有するピペリジン誘導体
|
|
WO2005035522A1
(en)
|
2003-10-08 |
2005-04-21 |
Pfizer Japan, Inc. |
1-‘2-(4-hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists
|
|
WO2005035523A1
(en)
|
2003-10-08 |
2005-04-21 |
Pfizer Japan Inc. |
Fused lactam compounds
|
|
WO2005080317A2
(en)
|
2004-02-11 |
2005-09-01 |
Pfizer Japan, Inc. |
Therapeutic amide derivatives
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
RS50574B
(sr)
*
|
2004-05-24 |
2010-05-07 |
F. Hoffmann-La Roche Ag. |
(4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid 4-hidroksi-4-metil-piperidin-1-karboksilne kiseline
|
|
HU226977B1
(en)
|
2004-07-29 |
2010-04-28 |
Richter Gedeon Nyrt |
Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
|
|
HUP0401522A2
(en)
|
2004-07-29 |
2006-04-28 |
Richter Gedeon Vegyeszet |
New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
|
|
CN1993363A
(zh)
|
2004-08-03 |
2007-07-04 |
默克公司 |
1,3－二取代的杂芳基nmda/nr2b拮抗剂
|
|
US20090041751A1
(en)
|
2005-02-01 |
2009-02-12 |
University Of Medicine And Dentistry Of New Jersey |
Sepsis Prevention Through Adenosine Receptor Modulation
|
|
EP1874318A2
(en)
|
2005-04-19 |
2008-01-09 |
Merck & Co., Inc. |
N-alkyl-azacycloalkyl nmda/nr2b antagonists
|
|
US9107917B2
(en)
|
2005-05-13 |
2015-08-18 |
The Feinstein Institute For Medical Research |
Treatment of sepsis and inflammation with alpha2A adrenergic antagonists
|
|
WO2006129626A1
(ja)
|
2005-05-30 |
2006-12-07 |
Kyowa Hakko Kogyo Co., Ltd. |
[1,2,4]トリアゾロ[1,5-c]ピリミジン誘導体の製造法
|
|
EP1894930A4
(en)
|
2005-06-23 |
2010-06-23 |
Kyowa Hakko Kirin Co Ltd |
THIAZOLE DERIVATIVE
|
|
JPWO2006137465A1
(ja)
|
2005-06-24 |
2009-01-22 |
塩野義製薬株式会社 |
含窒素複素環誘導体
|
|
US20100048653A1
(en)
|
2005-07-14 |
2010-02-25 |
The University Of British Columbia |
Neuroprotective modulation of nmda receptor subtype activities
|
|
US7799947B2
(en)
|
2005-11-29 |
2010-09-21 |
Hammersmith Imanet Limited |
In vivo imaging compounds
|
|
WO2007063839A1
(ja)
|
2005-11-30 |
2007-06-07 |
Shionogi & Co., Ltd. |
シクロヘキサン誘導体
|
|
EP2520567A3
(en)
|
2006-02-23 |
2012-12-12 |
Shionogi & Co., Ltd. |
Nitrogen-containing heterocycle derivatives substituted with cyclic group
|
|
ATE457988T1
(de)
*
|
2006-06-26 |
2010-03-15 |
Schering Corp |
A2a-adenosin-rezeptor-antagonisten
|
|
RU2009121815A
(ru)
|
2006-11-09 |
2010-12-20 |
Сантр Де Решерш Пюблик Де Ля Сантэ (Lu) |
Применение антагониста аденозина
|
|
WO2008155778A2
(en)
|
2007-06-19 |
2008-12-24 |
Rajiv Gandhi Centre For Biotechnology |
Assay for detection of transient intracellular ca2+
|
|
WO2009025265A1
(ja)
|
2007-08-21 |
2009-02-26 |
Shionogi & Co., Ltd. |
ピペラジン誘導体
|
|
US20090181934A1
(en)
|
2007-10-17 |
2009-07-16 |
Novartis Ag |
Organic Compounds
|
|
AU2008317034A1
(en)
|
2007-10-24 |
2009-04-30 |
Janssen Pharmaceutica, N.V. |
Arylindenopyrimidines and their use as Adenosine A2a receptor antagonists
|
|
WO2009054544A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Eisai R & D Management Co., Ltd. |
Ampa receptor antagonists for parkinson's disease and movement disorders
|
|
EP2215073A4
(en)
|
2007-10-31 |
2011-04-06 |
Merck Sharp & Dohme |
SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
|
|
MX2010009649A
(es)
|
2008-03-27 |
2010-12-17 |
Evotecv Neurosciences Gmbh |
Metodos para tratar trastornos utilizando un antagonista selectivo del subtipo nr2b de nmda.
|
|
US8684624B2
(en)
|
2008-07-01 |
2014-04-01 |
Saint-Gobain Performance Plastics Rencol Limited |
Tolerance ring
|
|
WO2010003712A1
(de)
|
2008-07-09 |
2010-01-14 |
Siemens Aktiengesellschaft |
Verfahren, kommunikationsverbund und software zum auffinden von gesuchten objekten
|
|
EP2144462A1
(en)
|
2008-07-09 |
2010-01-13 |
Nokia Siemens Networks OY |
Reduced resource allocation parameter signalling
|
|
AU2009282822A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Richter Gedeon Nyrt. |
Methods for treating CNS disorders
|
|
AU2009296235A1
(en)
|
2008-09-29 |
2010-04-01 |
Gilead Sciences, Inc. |
Combinations of a rate control agent and an A-2-alpha receptor antagonist for use in multidetector computed tomography methods
|
|
US8536306B2
(en)
|
2008-10-01 |
2013-09-17 |
The Scripps Research Institute |
Human A2A adenosine receptor crystals and uses thereof
|
|
US8282042B2
(en)
|
2009-06-22 |
2012-10-09 |
The Boeing Company |
Skin panel joint for improved airflow
|
|
US8301311B2
(en)
|
2009-07-06 |
2012-10-30 |
Siemens Aktiengesellschaft |
Frequency-responsive wind turbine output control
|
|
US20110007639A1
(en)
|
2009-07-10 |
2011-01-13 |
Qualcomm Incorporated |
Methods and apparatus for detecting identifiers
|
|
US20110105540A1
(en)
|
2009-10-29 |
2011-05-05 |
Jackson Paul F |
2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST
|
|
DE102010026274A1
(de)
|
2010-07-06 |
2012-01-12 |
Voith Patent Gmbh |
Bremsanlage und Verfahren zum Einstellen eines Bremsmomentes einer solchen
|
|
AU2011306358B2
(en)
*
|
2010-09-24 |
2014-08-14 |
Impetis Biosciences Ltd. |
Fused tricyclic compounds as adenosine receptor antagonist
|